USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 22.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 19.10.2026 | 19.10.2026 | SEA Ltd. | Tianyu Hou | CFO | Verkauf | 21.709,20 USD |
| 19.10.2026 | 19.10.2026 | SEA Ltd. | Tianyu Hou | CFO | Verkauf | 28.329,08 USD |
| 19.10.2026 | 19.10.2026 | SEA Ltd. | Tianyu Hou | CFO | Verkauf | 387.667,68 USD |
| 19.10.2026 | 19.10.2026 | SEA Ltd. | Tianyu Hou | CFO | Verkauf | 430.924,18 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 44.550,00 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 66.479,60 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 22.111,20 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 44.142,00 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 65.958,80 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 197.644,36 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 306.322,11 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 227.553,12 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 581.384,46 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 566.689,66 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 674.228,30 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 141.130,37 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 281.515,83 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 973.132,56 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 475.012,12 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 86.166,53 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 128.906,81 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 193.087,98 USD |
| 19.10.2026 | 19.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 85.559,97 USD |
| 19.10.2026 | 20.10.2026 | Venture Global, Inc. | Jonathan W. Thayer | Chief Financial Officer | Verkauf | 1.411.243,03 USD |
| 19.10.2026 | 19.10.2026 | Venture Global, Inc. | Jonathan W. Thayer | Chief Financial Officer | Verkauf | 1.408.576,37 USD |
| 19.10.2026 | 19.10.2026 | Clover Health Investments, Corp. | Jamie L. Reynoso | CEO, Medicare Advantage | Verkauf | 17.931,06 USD |
| 19.10.2026 | 19.10.2026 | Veracyte, Inc. | Muna Bhanji | Director | Verkauf | 81.456,80 USD |
| 19.10.2026 | 19.10.2026 | Vtex | de Faria Mariano Gomide | Chief Executive Officer | Verkauf | 19.712,80 USD |
| 19.10.2026 | 19.10.2026 | Vtex | Carmo Thomaz Junior Geraldo Do | Chief Executive Officer | Verkauf | 19.664,72 USD |
| 19.10.2026 | 19.10.2026 | Exagen Inc. | Jorey Chernett | 10% Owner | Kauf | 104.440,00 USD |
| 19.10.2026 | 19.10.2026 | Energy Co. of Parana | Pedro Franco Sales | Director | Verkauf | 173.840,00 USD |
| 19.10.2026 | 19.10.2026 | Uxin Ltd. 🔥 Cluster | Kun Dai | Chief Executive Officer / Director | Kauf | 6.085,54 USD |
| 19.10.2026 | 19.10.2026 | NXG Nextgen Infrastructure Income Fund | Todd Sunderland | Kauf | 46.500,00 USD | |
| 19.10.2026 | 19.10.2026 | Nano-X Imaging Ltd. | Erez Meltzer | Chief Executive Officer / Director | Kauf | 11.250,00 USD |
| 19.10.2026 | 19.10.2026 | Nebius Group N.V. | Arne Grimme | Director | Kauf | 25.158,52 USD |
| 19.10.2026 | 19.10.2026 | Dolphin Entertainment, Inc. | William O'Dowd IV | Chief Executive Officer / Director / 10% Owner | Kauf | 4.916,20 USD |
| 19.10.2026 | 19.10.2026 | City Therapeutics, Inc. 🔥 Cluster | ARCH Venture Partners XII, LLC | 10% Owner | Kauf | 3.060.000,00 USD |
| 19.10.2026 | 19.10.2026 | Cloudflare, Inc. | Carl Ledbetter | Director | Verkauf | 337.989,84 USD |
| 19.10.2026 | 19.10.2026 | Cloudflare, Inc. | Carl Ledbetter | Director | Verkauf | 597.683,25 USD |
| 19.10.2026 | 19.10.2026 | Cloudflare, Inc. | Carl Ledbetter | Director | Verkauf | 586.320,73 USD |
| 19.10.2026 | 19.10.2026 | Guidewire Software, Inc. | Michael George Rosenbaum | Chief Executive Officer / Director | Verkauf | 201.480,00 USD |
| 19.10.2026 | 19.10.2026 | Equity Bancshares Inc. | Leon Borck | Director | Kauf | 18.536,40 USD |
| 18.10.2026 | 19.10.2026 | Solid Biosciences Inc. | Gabriel Brooks | Chief Medical Officer | Verkauf | 24.581,88 USD |
| 18.10.2026 | 19.10.2026 | Upwork, Inc. | Anthony Ray Kappus | GM & Chief Operating Officer | Verkauf | 4.711,98 USD |
| 17.10.2026 | 19.10.2026 | Oklo Inc. | Vivek Narayanadas | General Counsel & Secretary | Verkauf | 65.179,17 USD |
| 16.10.2026 | 19.10.2026 | Ginkgo Bioworks Holdings, Inc. | Jason R. Kelly | See remarks / Director | Verkauf | 463.352,53 USD |
| 16.10.2026 | 19.10.2026 | Ginkgo Bioworks Holdings, Inc. | Reshma P. Shetty | See remarks / Director / 10% Owner | Verkauf | 190.718,83 USD |
| 16.10.2026 | 19.10.2026 | Ginkgo Bioworks Holdings, Inc. | Reshma P. Shetty | See remarks / Director / 10% Owner | Verkauf | 226.888,77 USD |
| 16.10.2026 | 19.10.2026 | Ginkgo Bioworks Holdings, Inc. | Barry Canton | 10% Owner | Verkauf | 226.888,77 USD |
| 16.10.2026 | 19.10.2026 | Ginkgo Bioworks Holdings, Inc. | Barry Canton | 10% Owner | Verkauf | 190.718,83 USD |